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Abstract
Background: It has been estimated that about 45% of abstracts that are accepted for presentation
at biomedical meetings will subsequently be published in full. The acceptance of abstracts at
meetings and their fate after initial rejection are less well understood. We set out to estimate the
proportion of abstracts submitted to meetings that are eventually published as full reports, and to
explore factors that are associated with meeting acceptance and successful publication.
Methods: Studies analysing acceptance of abstracts at biomedical meetings or their subsequent full
publication were searched in MEDLINE, OLDMEDLINE, EMBASE, Cochrane Library, CINAHL,
BIOSIS, Science Citation Index Expanded, and by hand searching of bibliographies and proceedings.
We estimated rates of abstract acceptance and of subsequent full publication, and identified
abstract and meeting characteristics associated with acceptance and publication, using logistic
regression analysis, survival-type analysis, and meta-analysis.
Results: Analysed meetings were held between 1957 and 1999. Of 14945 abstracts that were
submitted to 43 meetings, 46% were accepted. The rate of full publication was studied with 19123
abstracts that were presented at 234 meetings. Using survival-type analysis, we estimated that 27%
were published after two, 41% after four, and 44% after six years. Of 2412 abstracts that were
rejected at 24 meetings, 27% were published despite rejection. Factors associated with both
abstract acceptance and subsequent publication were basic science and positive study outcome.
Large meetings and those held outside the US were more likely to accept abstracts. Abstracts were
more likely to be published subsequently if presented either orally, at small meetings, or at a US
meeting. Abstract acceptance itself was strongly associated with full publication.
Conclusions: About one third of abstracts submitted to biomedical meetings were published as
full reports. Acceptance at meetings and publication were associated with specific characteristics
of abstracts and meetings.
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Background
Dissemination of results from research is a key feature of
biomedical science. Over 40 years ago, the filtering proc-
ess from the stage of designing a study until publication of
the results was likened to a biological metabolism [1].
Abstracts that are presented at biomedical meetings often
provide the first evidence of a research activity. Since
abstracts are usually published in proceeding volumes or
in journal supplements, they can be followed up until suc-
cessful publication as full reports. Thus, through follow-
up of abstracts from meeting submission to subsequent
full publication, some aspects of this "metabolism" [1]
can be studied. Systematic review of reports that focused
on the follow-up of meeting abstracts identified some spe-
cific characteristics of the abstracts that were associated
with successful publication [2,3]. The average publication
rate of abstracts was shown to be about 45% only, suggest-
ing that more than half were not fully published after
presentation at the meetings [2,3]. Despite this important
finding, some elements of the selection process of scien-
tific data remained unclear. For instance, it is not well
understood what happens to abstracts submitted for pres-
entation at meetings. The rate of meeting acceptance has
not been subject to systematic review, and factors that
determine acceptance of abstracts at meetings have not
been systematically investigated. Finally, the rate of
abstracts that are rejected at meetings but still published is
unclear. This additional knowledge would improve our
understanding on the "metabolism" of scientific data.
Our study focused on five objectives. First, to estimate,
based on published data, the acceptance rate of abstracts
submitted to biomedical meetings. Second, to better
describe the time-course of subsequent full publication of
abstracts. Third, to identify abstract and meeting charac-
teristics that are associated with abstract acceptance at
meetings and their subsequent publication. Fourth, to
investigate the fate of rejected abstracts. And fifth, to esti-
mate the rate of abstracts that are submitted to biomedical
meetings and, whether accepted at the meetings or not,
subsequently published in full.
Methods
Dissemination of biomedical information
We defined three flows of abstracts (Figure 1). Flow 1
described abstracts that were submitted to a meeting and
accepted for presentation. Flow 2 described accepted
abstracts that were published subsequently as full reports.
Flow 3 described abstracts rejected by a meeting that were
published subsequently despite rejection. Abstracts were
considered as unpublished if they could not be retrieved
as full reports, including papers that were still in the pub-
lishing process (in press), not easily accessible (grey liter-
ature), or not published at all (file drawer).
Systematic search
We searched in MEDLINE, OLDMEDLINE, EMBASE,
Cochrane Library, CINAHL, and BIOSIS for studies that
provided data on Flows 1 to 3. Searches were conducted
until March 31, 2001 without restriction for language or
publication format. The search strategy included multiple
free text keywords and combinations thereof: abstract,
summary report, poster, poster presentation, oral presentation,
podium presentation, presented, meeting, congress, conference,
convention, submission, submitted, acceptance, accepted,
acceptance rate, rejection, rejected, publication, published, pub-
lication rate, and publication pattern. Fate was searched as a
title word. Citations of previously published similar anal-
ysis [3] were searched using Science Citation Index
Expanded [4]. Bibliographies of retrieved articles, and the
proceedings of the first three International Congresses on
Peer Review in Biomedical Publication were checked.
Authors were contacted to clarify ambiguity in the reports
and to provide supplementary data if necessary. Internet
searches were conducted for additional information on
the meetings.
Inclusion / exclusion criteria
We included reports on the acceptance of abstracts sub-
mitted to biomedical meetings and follow-up studies on
the full publication of abstracts submitted to or accepted
at biomedical meetings. Only studies on individual and
identifiable biomedical meetings were included; studies
on large thematic collections of abstracts from a variety of
meetings were excluded. We checked whether there was
overlap in the included meetings. Reports on meetings in
social science including psychology were excluded.
Reported details on follow-up period, the searched data-
bases and other sources, and the procedure used to match
an abstract with its corresponding full publication were
identified as indicators of methodological quality of fol-
low-up studies. For inclusion, these key components had
to be described adequately.
Data extraction
For each identifiable meeting we extracted information on
the most frequently reported meeting characteristics;
these were year, country, size, and speciality of the meet-
ing. We hypothesised that they may be associated with
meeting acceptance and full publication of abstracts. Size
was defined as the number of abstracts presented at the
meeting. Data from related specialities (for instance,
anaesthesia and emergency medicine) were combined.
When a report provided information on more than one
meeting, data were extracted separately for each meeting.
We also extracted dichotomous data on abstract character-
istics that were potentially associated with acceptance or
subsequent publication, for instance, study outcomeBMC Medical Research Methodology 2003, 3 http://www.biomedcentral.com/1471-2288/3/12
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(positive / negative), topic of research (basic / clinical),
and type of presentation (oral / poster). Definitions of
these characteristics were taken as provided in the original
reports.
Two investigators extracted all relevant data independ-
ently; discrepancies were resolved by discussion with the
other investigators.
Statistical analyses
Acceptance rate was defined as ratio of number of
accepted abstracts to number of submitted abstracts. Mul-
tiple logistic regression was used to investigate associa-
tions between abstract acceptance and meeting
characteristics. Results were expressed as adjusted odds
ratios (OR) with 95% confidence intervals (95%CI).
Publication rate was defined as ratio of number of subse-
quently published abstracts to total number of accepted
abstracts. The delays until full publication were used as
time-to-event data for survival-type analyses. Full publica-
tion was defined as the event; abstracts that remained
unpublished were censored at time of last follow-up.
Results were plotted as Kaplan-Meier (product limit)
curves. A follow-up interval was defined as the delay
between time points at which publication rates were
reported during the follow-up period. For instance, if pub-
lication rates were reported for each year elapsed since the
date of the meeting, the follow-up interval was one year.
The average follow-up interval was calculated for each
included meeting. We assumed that publication occurred
always at the end of the follow-up intervals. Since average
follow-up intervals of meetings varied, we performed sen-
sitivity analyses using different maximum lengths of aver-
age follow-up intervals. Differences in subsequent full
Flows of abstracts from submission to a meeting until full publication Figure 1
Flows of abstracts from submission to a meeting until full publication.
Abstract submission
to meeting
FLOW 1
Rejection Acceptance
(Presentation)
FLOW 2 FLOW 3
Full publicationBMC Medical Research Methodology 2003, 3 http://www.biomedcentral.com/1471-2288/3/12
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publication according to meeting characteristics were
investigated using logrank tests.
Data on abstract characteristics were combined using the
Mantel-Haenszel method and a fixed-effect model.
Results were expressed as odds ratios (OR) with 95% con-
fidence intervals (95%CI).
Results
Retrieved and analysed studies
We retrieved 84 potentially relevant reports. We excluded
14: three were not about biomedical meetings [5–7], six
were on collections of abstracts across meetings that were
not identifiable individually [8–13]; and in five, relevant
data could not be extracted [14–18]. We analysed data
from 64 studies published in 70 reports [1,3,19–86] (see
Additional file 1). Four of those studies were published in
two full reports each and with partial overlap of the data
[1,45,46,50,51,62,74,84]. Another study was published
in three abstracts with substantial redundancy of the
reported data [79–81]. All redundant data were
disregarded.
Flow 1 – From submission to acceptance
Twenty-one studies provided information on Flow 1
(Additional file 1, Figure 1). Of two studies reporting on
the same meeting [21,79], only one was included [21].
The 20 remaining studies reported on 43 biomedical
meetings held between 1976 and 1999 (median, 1990).
Most meetings (79%) were in paediatrics (37%), internal
medicine (28%), or surgery (14%). Of 14945 submitted
abstracts, 6815 (46%) were accepted. The lowest accept-
ance rate was 25% [78], and the highest was 86% [23].
Abstracts were more likely to be accepted when the meet-
ing was held after 1990, when it took place outside the US,
or when it was larger than the median size (89 abstracts)
of the meetings (Table 1). Abstracts submitted to an inter-
nal medicine or paediatric meeting were accepted more
often than those submitted to a surgical meeting. Abstract
characteristics that were associated with acceptance at
meetings were basic science and positive outcome (Table
2).
Flow 2 – From acceptance to subsequent publication
Fifty studies provided information on Flow 2 (Additional
file 1, Figure 1). They reported on 19123 abstracts pre-
sented at 234 biomedical meetings held between 1957
and 1998 (median, 1992). The majority (53%) of meeting
specialities were surgery (25%), internal medicine (13%),
anaesthesia/emergency medicine (9%), and paediatrics
(6%); the remaining 47% comprised a broad range of 27
different specialities.
There were large variations in both follow-up periods
(range, 8 months [73] to 300 months [39]) and publica-
tion rates (range, 0%[53] to 82% [53]). Numerous studies
reported on only one publication rate resulting in one
long follow-up interval. In sensitivity analyses, the shape
of the Kaplan-Meier curve differed depending on the max-
imum length of the average follow-up interval (Figure 2).
Average follow-up intervals ≤ 1 year were provided for a
subgroup of 6383 abstracts or 33% of all abstracts. For
those, the publication rate after one year was 12% (95%CI
11–13%), after two years was 27% (26–29%), after three
years was 37% (36–38%), after four years was 41% (40–
43%), and after six years was 44% (43–46%). The shape
of the Kaplan-Meier curve suggested a plateau at about
45%; however, there was little data for follow-up periods
longer than six years. Including data from studies with an
average follow-up interval of up to two years did not
change the shape of the curve. When studies with an aver-
age follow-up interval of up to four years or all studies
were included, the analyses tended to yield lower publica-
tion rates until the fourth to sixth year, and higher publi-
cation rates thereafter (Figure 2).
To investigate meeting characteristics, only the subgroup
of studies with the most detailed follow-up intervals
(average ≤ 1 year) was analysed. Meetings smaller than the
median size (109 abstracts), and US meetings (as com-
pared to all other countries) were associated with an
increased likelihood of subsequent publication (Figure
3). Abstracts from paediatric meetings tended to have a
higher publication rate than those from surgery meetings
which, in turn, were published more often than those
from anaesthesia/emergency medicine meetings. For
meetings held after 1992 (median) versus before there
was no clear difference between Kaplan-Meier curves.
Abstract characteristics that were associated with subse-
quent publication were basic science, positive outcome,
and oral presentation (Table 3). Study sample size, inves-
tigated in two reports, had no impact on rates of subse-
quent publication [3,43].
Flow 3 – Full publication despite meeting rejection
Nine studies provided information on Flow 3, with eight
of those reporting on analysable data on the fate of both
accepted and rejected abstracts (Additional file 1, Figure
1). These eight studies reported on 4414 abstracts submit-
ted to 24 biomedical meetings held between 1976 and
1995. Most meetings were in paediatrics (50%), internal
medicine (25%), or surgery (17%). Follow-up periods
ranged from 36 months [3] to 88 months [77]. Full
publications were identified for 1042 (52%) of 2002
accepted abstracts, and for 641 (27%) of 2412 rejected
abstracts, respectively. Abstract acceptance was strongly
associated with full publication (OR 2.95, 95%CI 2.59–
3.36).BMC Medical Research Methodology 2003, 3 http://www.biomedcentral.com/1471-2288/3/12
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In four studies, authors were queried on the reasons why
their manuscript had not been published [3,75,82,84]. Of
549 valid responses, lack of time was the most cited rea-
son (31%), followed by low priority (21%), prior rejec-
tion (10%), problems with co-authors (9%), anticipated
rejection (8%), and negative study results (3%).
How many abstracts get published?
The number of submitted abstracts (accepted or not) that
were eventually published in full could be estimated in
two different ways. First, in 11 studies (39 meetings),
abstracts were followed up from submission to full publi-
cation [73–79,82,83,85,86]. Follow-up times ranged
from 8 to 127 months. Of 7672 abstracts that were sub-
mitted to biomedical meetings, 2415 (31%) were eventu-
ally published in full.
The second estimation yielded a very similar number. Of
all submitted abstracts, about 46% were accepted for pres-
entation, while 54% were rejected (Flow 1). Of the
accepted abstracts, 44% (20% of all submissions) were
subsequently published as full reports within six years
(Flow 2). Of the rejected abstracts, 27% (15% of all
submissions) were published as full reports despite rejec-
tion (Flow 3). Taken together, of all submitted abstracts,
35% were eventually published.
Discussion
About one third of abstracts submitted to biomedical
meetings is eventually published as full reports. This esti-
mation was derived from two different methodological
approaches and both gave very similar results. It is based
on the assumption that the analysed abstracts are repre-
sentative samples of all abstracts. Also, for rejected
abstracts, the time-course until publication remained
obscure. However, the estimate implies that about 2/3 of
all submitted biomedical research abstracts will not get
published. Selective underreporting of research may be
seen as a form of scientific misconduct [87], and it may
result in publication bias. It is important, therefore, to
understand why some abstracts are accepted at meetings
and others are not, and why some of the accepted
abstracts are published subsequently and others are not.
Ideally, all published full reports are based on data from
sound scientific studies. Accordingly, peer review of meet-
Table 1: Flow 1, from submission to acceptance. Meeting characteristics associated with abstract acceptance
Meeting characteristic Number of abstracts Odds ratio* 95% conf. interval
Year (median: 1990)
1990 or before 8828 1.00
After 1990 6117 1.55 1.43–1.68
Country
US 12540 1.00
Other§ 2405 1.50 1.33–1.69
Size (median: 89 abstracts)
Smaller than median 2764 1.00
Larger than median 12181 1.35 1.22–1.49
Speciality†
Surgery 1594 1.00
Paediatrics 4634 1.19 1.02–1.39
Internal medicine 4182 1.50 1.30–1.72
*Odds ratio > 1 indicates a higher likelihood of acceptance compared with the reference group. §Canada, Germany, UK †Only specialities with 5 or 
more meetings are included
Table 2: Flow 1, from submission to acceptance. Meta-analyses of abstract characteristics associated with abstract acceptance.
Abstract characteristic Accepted / submitted 
abstracts
Accepted / submitted 
abstracts
Odds ratio (95% conf. interval)
Topic of research [19,22,23] Basic vs clinical 131 / 216(61%) 155/491 (32%) 3.49 (2.50–4.86)
Outcome of studies [75,76] Positive vs negative 95/162(59%) 233/485 (48%) 1.67(1.16–2.39)BMC Medical Research Methodology 2003, 3 http://www.biomedcentral.com/1471-2288/3/12
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ings and journals may be regarded as a putatively laudable
mechanism to filter out invalid studies. Abstract accept-
ance and oral presentation were associated with subse-
quent full publication. One might hypothesise that only
the most valid studies would be selected for presentation
at the meetings, and that among those only the best
would be chosen for oral presentation and for subsequent
full publication. Unfortunately, there is no reliable
evidence to support this view. One report found prospec-
tive study design, affiliation with a university, and ran-
domisation to be associated with abstract acceptance [76].
Another report showed an association between the origi-
nality of a study and abstract acceptance [74]. However, in
the same report, a quality score was not significantly asso-
ciated with abstract acceptance [74].
We identified five factors that possibly play a role when
abstracts are filtered on their way from meeting submis-
sion to subsequent publication. First, abstracts that
reported on a positive study outcome were more likely to
be published subsequently, as already shown in a previ-
ous analysis [2,3]. Positive outcome was defined differ-
ently in the included studies; we decided to combine these
data despite diverging definitions. When authors were
asked why their study had remained unpublished, less
than 5% indicated that a negative study result was the rea-
son [82,84]. Low priority, anticipated rejection, or lack of
time were more often cited, but these reasons may be
related to negative study outcome [82,84]. When
investigators were surveyed for reasons of non-comple-
tion or non-submission of work initially presented at a
meeting, similar answers were found [88]. Our analysis
provides evidence that positive outcome bias is likely to
Flow 2, from abstract acceptance to subsequent full publication Figure 2
Flow 2, from abstract acceptance to subsequent full publication. Combined (Kaplan-Meier) publication rates with sensitivity 
analyses.
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occur already at an earlier stage, i.e. at abstract submis-
sion. Peers who select abstracts submitted to biomedical
meetings might favour studies that report on positive
results. The authors themselves may be not only less
enthusiastic about publication of negative study results
[89], but also about their prior submission to scientific
meetings.
Flow 2, from abstract acceptance to subsequent publication Figure 3
Flow 2, from abstract acceptance to subsequent publication. Meeting characteristics associated with full publication.
Table 3: Flow 2, from abstract acceptance to subsequent publication. Meta-analyses of meeting characteristics associated with full 
publication
Abstract characteristic Fully published / accepted 
abstracts
Fully published / accepted 
abstracts
Odds ratio (95% conf. interval)
Topic of research [44,48,51,52,54,60] 
Basic vs clinical
239/401 (60%) 1218/2991 (41%) 2.29 (1.75–2.98)
Outcome of studies [3,43,52,54,63,75] 
Positive vs negative
262 / 471 (56%) 236/515 (46%) 2.07 (1.58–2.71)
Presentation [31,43,50,56,76] Oral vs 
poster
239/518 (46%) 212/571 (37%) 1.53 (1.15–2.03)
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Second, abstracts that reported on basic (as opposed to
clinical) research were more likely to be accepted at bio-
medical meetings and to be published subsequently. Dif-
ferences in the quality of conducting and reporting of
basic and clinical research may explain this finding. How-
ever, in both domains, studies that investigated the
relationship between the quality of abstracts and their
likelihood of publication came to contradictory conclu-
sions [22,90]. Whether the abstracts included in the ana-
lysed follow-up studies were representative for basic or
clinical research could not be assessed. It is conceivable
that, in basic research, only the most important findings
were submitted for presentation and later published.
When chairpersons and senior research advisors were
asked to rate robustness and quality of research projects
performed in their departments, they consistently rated
basic research highest [91]. Assuming a significant
involvement of these research leaders in the reviewing of
meeting abstracts and journal manuscripts, this implies
the existence of a bias in favour of basic research.
Third, meetings comprising a larger number of abstracts
had higher acceptance rates. But abstracts presented at
smaller meetings were more likely to be published subse-
quently. Since meeting organisers often wish to attract the
maximum number of attendees, a less rigorous selection
of abstracts may result for larger meetings. At smaller
meetings the peer review process may be more stringent,
leading to selection of higher-quality papers that, in turn,
would be more likely to be published eventually. How-
ever, numerous factors determine the size of a meeting
and make the relationship with the acceptance of abstracts
difficult to interpret.
Fourth, abstracts submitted to US meetings were accepted
less often, but when accepted, were more likely to be pub-
lished subsequently. This suggests that filtering mecha-
nisms at US meetings are different from those at non-US
meetings, but once again other underlying factors may
play a role.
Fifth, the most frequently investigated specialities had dif-
ferent rates of acceptance and publication. Internal medi-
cine and paediatrics had higher abstract acceptance rates
than surgery. Paediatrics and surgery meetings had higher
full publication rates than anaesthesia/emergency medi-
cine meetings.
The analysed reports did not allow to explain these
disparities.
Choosing an appropriate statistical approach for combin-
ing the time-to-event data presented a methodological
challenge since publication rates were reported in widely
varying average follow-up intervals. In previous analyses a
single publication rate after the median follow-up time
was calculated [2,3]. We estimated the time-course of
publication rates using the techniques of survival analysis.
Then we performed sensitivity analyses by excluding data
from reports with less detailed follow-up intervals. Based
on reports with the most detailed follow-up (intervals ≤ 1
year), the publication rates increased to about 44% at six
years after meeting presentation. When data from reports
with longer follow-up intervals were included in the
analyses, estimates differed. Generally, publication rates
were lower for observation periods up to six years, and
were higher for those longer than six years. Thus, for this
type of combined time-to-event analyses, there may be an
argument to only include data from studies with short fol-
low-up intervals, i.e. more detailed follow-up.
Often, acceptance rates were reported as a secondary out-
come of studies that investigated the functioning of scien-
tific meeting committees. Therefore, we may have missed
other relevant studies, and the retrieved studies may not
be representative. Also, the methodology of included
studies varied with regard to the length of follow-up after
a meeting, follow-up intervals, type and number of data
sources, and criteria of matching between abstracts and
subsequent full reports. In an attempt to take this hetero-
geneity into account, we conducted sensitivity analyses
with subgroups of studies with different maximum fol-
low-up intervals. This resulted in different Kaplan-Meier
curves.
We decided pre hoc to exclude studies on collections of
abstracts that originated from a variety of meetings, since
they did not provide information on the individual meet-
ings. Two studies with good methodological quality were
among those [8,9]. The publication rate of abstracts from
the Oxford Database of Perinatal Trials was reported to be
39% after at least four years of follow-up [8]. For abstracts
collected by the Cochrane Cystic Fibrosis Group, the pub-
lication rate after five years was 40% [9].
There are still unresolved questions, and these could be
addressed in further studies. For instance, we did not
study what happens to scientific data before abstract
submission, nor did we look at alternative pathways of
dissemination. An unknown number of manuscripts are
submitted to journals directly and arrive at full publica-
tion without former presentation at meetings. Also, crite-
ria applied by peers to select abstracts for meeting
presentation are not well understood. Finally, we could
not draw any conclusions on the relationship between
study quality and the likelihood of abstract acceptance
and subsequent full publication.BMC Medical Research Methodology 2003, 3 http://www.biomedcentral.com/1471-2288/3/12
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Conclusions
Of abstracts that are submitted to biomedical meetings,
only about one third is subsequently published in full.
Both meeting acceptance and full publication are associ-
ated with specific characteristics of the abstracts them-
selves and of the meetings. Our study confirms knowledge
from previous similar analyses that concentrated on the
flow of scientific data from presentation at a meeting to
subsequent full publication [2,3]. It integrates this previ-
ous knowledge with additional relevant information, i.e.
the rate of abstract acceptance at meetings, and the fate of
rejected abstracts. Thus, our analysis adds to an improved
understanding of how scientific data are disseminated.
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